Bortezomib (2 mg)

Bortezomib (2 mg)

Arsenox 10 mg Injection contains Arsenic Trioxide (10 mg) and is an antineoplastic medicine used in the treatment of acute promyelocytic leukemia (APL) by inducing apoptosis and promoting cancer cell differentiation.

- +

Form: Injection

Manufacturer: Generic Pharmaceuticals

Country of Origin: India

Overview: Arsenox 10 mg Injection contains Arsenic Trioxide (10 mg) and is a prescription antineoplastic medicine used in the treatment of acute promyelocytic leukemia (APL) by inducing apoptosis and promoting differentiation of leukemia cells. Key Benefits: – Effective targeted therapy for APL – Helps induce cancer cell death and differentiation – Administered under clinical supervision Composition: Arsenic Trioxide (10 mg) How It Works: Arsenic Trioxide works by inducing apoptosis (programmed cell death) and promoting differentiation of malignant promyelocytic leukemia cells, leading to reduced tumor burden and improved disease control. Usage Instructions: – Administer only under the supervision of qualified healthcare professionals – Dosage and schedule determined by oncologist based on patient condition – Not for self-administration Side Effects: – Nausea, vomiting, fatigue – QT interval prolongation, electrolyte imbalance – Headache, fever Precautions: – Monitor cardiac function, electrolytes and blood counts regularly during treatment – Not recommended during pregnancy or breastfeeding unless advised by a physician – Inform your doctor of all current medications Storage Instructions: – Store below 25°C, protect from light, do not freeze Manufacturer: Generic Pharmaceuticals Disclaimer: To be sold by retail on the prescription of a registered medical practitioner only.

Composition

Arsenic Trioxide (10 mg)

Pack Size

1 Vial

Form

Injection

Manufacturer

Generic Pharmaceuticals

Brand

Arsenox

Country of Origin

India

Strength

10 mg

Usage Category

Anticancer / Chemotherapy Medicines

Storage Conditions

do not freeze, protect from light, Store below 25°C

Prescription Required

Yes

Administration Route

Injection (Intravenous)

Dosage Form

Injection

Marketed By

Generic Pharmaceuticals

Reviews

There are no reviews yet.

Be the first to review “Bortezomib (2 mg)”

Your email address will not be published. Required fields are marked *

Requirement List
Scroll to Top